Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

Autor: Mulders, M.C.F., Audhoe, A.S., Van Koetsveld, P.M., Feelders, R.A., Hofland, L.J., de Herder, W.W., Kraaij, R., Hofland, J.

Publikováno v: In European Journal of Cancer January 2024 197

Improved Localization of Insulinomas Using ⁶⁸ Ga-NODAGA-Exendin-4 PET/CT.

Autor: Boss M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands; marti.boss@radboudumc.nl., Eriksson O; Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Mikkola K; Turku PET Center, University of Turku, Turku, Finland., Eek A; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Brom M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Buitinga M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Brouwers AH; Department of Nuclear Medicine, University Medical Center Groningen, Groningen, The Netherlands., Velikyan I; Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Waser B; Pathology Länggasse, Bern, Switzerland., Kauhanen S; Turku PET Center, University of Turku, Turku, Finland.; Department of Gastrosurgery, Turku University Hospital, Turku, Finland., Solin O; Turku PET Center, University of Turku, Turku, Finland., Marciniak C; Department of General and Endocrine Surgery, University Hospital Lille, Lille, France., Eriksson B; Section for Endocrine Oncology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Reubi JC; Institute of Pathology, Cell Biology and Experimental Cancer Research, University of Bern, Bern, Switzerland., Aveline C; Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France., Wild D; Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.; Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Basel, Switzerland., Pattou F; Department of General and Endocrine Surgery, University Hospital Lille, Lille, France., Talbot JN; Department of Nuclear Medicine, Hôpital Tenon, AP-HP, Paris, France., Hofland J; Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Sundin A; Department of Surgical Sciences, Radiology and Molecular Imaging, Uppsala University, Uppsala, Sweden; and., Nuutila P; Turku PET Center, University of Turku, Turku, Finland.; Department of Endocrinology, Turku University Hospital, Turku, Finland., Hermans J; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Clinical impact of using [ ¹⁸ F]AlF-NOTA-octreotide PET/CT instead of [ ⁶⁸ Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

Autor: Leupe H; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Pauwels E; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Vandamme T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital & NETwerk Antwerpen-Waasland CoE, Edegem, Belgium., Van den Broeck B; Nuclear Medicine, Ghent University Hospital, Ghent, Belgium., Lybaert W; Department of Oncology, Antwerp University Hospital & NETwerk Antwerpen-Waasland CoE, Edegem, Belgium., Dekervel J; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Van Herpe F; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Jaekers J; Department of Visceral Surgery, University Hospitals Leuven, Leuven, Belgium., Cleeren F; Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Hofland J; Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence Rotterdam, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brouwers A; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Koole M; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Bormans G; Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Van Cutsem E; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Geboes K; Digestive Oncology, Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium., Laenen A; Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium., Verslype C; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Stroobants S; Nuclear Medicine, Antwerp University Hospital & Molecular Imaging and radiology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium., Deroose CM; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium.

Publikováno v: Journal of neuroendocrinology [J Neuroendocrinol] 2024 Aug; Vol. 36 (8), pp. e13420. Date of Electronic Publication: 2024 Jun 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.

Autor: Mulders MCF; ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC & Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands., de Herder WW; ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC & Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands., Hofland J; ENETS Center of Excellence, Section of Endocrinology, Department of Internal Medicine, Erasmus MC & Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.

Publikováno v: Endocrine reviews [Endocr Rev] 2024 May 07; Vol. 45 (3), pp. 351-360.